Katiuscia Dallaglio

Katiuscia Dallaglio is an accomplished R&D Project Leader at Chiesi Group, specializing in Advanced Therapies for Rare Diseases since April 2017, with prior experience as an R&D Preclinical Scientist in the same field. Katiuscia has a substantial research background, including a post-doctoral fellowship focused on human melanoma stem cells at Translational Research Lab. Arcispedale Santa Maria Nuova IRCCS, and previous roles as a Research Collaborator and Scientist at various institutions, concentrating on topics such as chemoprevention, tumor microenvironments, and apoptosis in skin cancer. Katiuscia's educational credentials include a Clinical Pathology degree and a Ph.D. in Molecular Medicine and Regenerative Medicine from Università degli Studi di Modena e Reggio Emilia, complemented by a Master’s and Bachelor's degree in Biotechnology from the same university.